Literature DB >> 4949498

Cell-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

M R Venneman, L J Berry.   

Abstract

Peritoneal cells obtained from mice immunized 15 or 30 days previously with (i) 0.1 LD(50) of attenuated Salmonella typhimurium (RIA), (ii) 20 mug (dry weight) of heat-killed Salmonella (SR-11), (iii) 20 mug (dry weight) of immunogenic ribosomal subfractions, or (iv) 20 mug of ribonucleic acid (RNA) subfractions were passively transferred to normal unimmunized mice. The ability of the recipient animals to inhibit or retard the multiplication of virulent challenge S. typhimurium 5 days post-infection was determined by pathogen counts on the carcasses. Peritoneal cells from donors immunized with the RIA, ribosomal, or RNA preparations (i) conferred maximal resistance to challenge 10 to 15 days after cell transfer and demonstrable resistance throughout the 45-day assay period, (ii) conferred resistance to infection when 10(5), 10(3), or 10(2) peritoneal cells were injected subcutaneously but not with fewer than 10(5) cells administered intraperitoneally, and (iii) rendered recipients capable of acting as donors of peritoneal cells that conferred demonstrable resistance on normal recipients. Recipients of peritoneal cells obtained from donors immunized with heat-killed bacteria were unable to (i) significantly inhibit bacterial proliferation at 10 days post-transfer, (ii) resist infection by a challenge inoculum greater than 50 LD(50), and (iii) secondarily confer resistance on normal animals through the passive transfer of cells or serum.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4949498      PMCID: PMC416317          DOI: 10.1128/iai.4.4.381-387.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  PARTIAL PURIFICATION OF THE "PROTECTIVE" ANTIGEN OF SALMONELLA TYPHIMURIUM AND ITS DISTRIBUTION AMONGST VARIOUS STRAINS OF BACTERIA.

Authors:  C R JENKIN; D ROWLEY
Journal:  Aust J Exp Biol Med Sci       Date:  1965-02

2.  Experimental Salmonellosis VI. In Vitro Transfer of Cellular Immunity of Mouse Mononuclear Phagocytes.

Authors:  K Saito; S Mitsuhashi
Journal:  J Bacteriol       Date:  1965-09       Impact factor: 3.490

3.  Antibody response and protection induced by immunization with smooth and rough strains in experimental salmonellosis.

Authors:  K Kenny; M Herzberg
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

4.  Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

Authors:  M R Venneman; L J Berry
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

5.  Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

6.  Experimental salmonellosis. X. Cellular immunity and its antibody in mouse mononuclear phagocytes.

Authors:  S Kurashige; N Osawa; M Kawakami; S Mitsuhashi
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

7.  Experimental salmonellosis. VII. Comparison of the immunizing effect of live vaccine and materials extracted from Salmonella enteritidis.

Authors:  M Kawakami; N Osawa; S Mitsuhashi
Journal:  J Bacteriol       Date:  1966-12       Impact factor: 3.490

8.  Heat-labile antigens of Salmonella enteritidis. II. Mouse-protection studies.

Authors:  F M Collins; M Milne
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

9.  Experimental salmonellosis. VII. In vitro transfer of cellular immunity by ribosomal fraction of mouse mononuclear phagocytes.

Authors:  I Sato; S Mitsuhashi
Journal:  J Bacteriol       Date:  1965-11       Impact factor: 3.490

10.  Mechanisms of acquired resistance in mouse typhoid.

Authors:  R V Blanden; G B Mackaness; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  22 in total

1.  Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.

Authors:  P Hoops; N E Prather; J Berry; J M Ravel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

2.  Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction.

Authors:  C L Swendsen; W Johnson
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

3.  Common bacterial infections in infancy and childhood. 6. Enteric infections.

Authors:  M I Marks
Journal:  Drugs       Date:  1978-09       Impact factor: 9.546

Review 4.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

5.  Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals.

Authors:  K H Wong; J C Feeley; R S Northrup; M E Forlines
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

6.  Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

Authors:  M R Venneman; L J Berry
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

7.  Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

8.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

9.  Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

10.  Comparative dynamics of salmonella infection after primary and secondary challenge of mice exposed to 10 and 23 C.

Authors:  J J Previte; J C Alden; M Egbert
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.